|
|
 Previous Article | Table of Contents | Next Article 
Novel Interaction of Apolipoprotein(a) With  -2 Glycoprotein I Mediated by the Kringle IV Domain
Silvano Köchl,
Friedrich Fresser,
Eva Lobentanz,
Gottfried Baier, and
Gerd Utermann
From the Institute for Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria.
Lipoprotein(a) [Lp(a)], which has been shown to interact with fibrin(ogen) and other components of the blood clotting cascade, is a major independent risk factor for atherothrombotic disease in humans. The physiological function(s) of Lp(a), as well as the precise mechanism(s) by which high plasma levels of Lp(a) increase risk are unknown. Identification of further potential apo(a)-protein ligands may be crucial to illuminate apo(a)'s function(s) and pathophysiological properties. We used the repetitive apo(a) kringle IV type 2, which is variable in number in apo(a), to screen a human liver cDNA library by the yeast two-hybrid interaction trap system. Among 11 positive clones that emerged from the screen, eight clones were identified as  -2 glycoprotein I and one as fibronectin. Coimmunoprecipitation experiments confirmed that -2 glycoprotein I and apo(a)/Lp(a) interact in human plasma and in cell culture supernatants of COS-1 cells, which ectopically expressed apo(a). The apo(a)-2-glycoprotein I interaction indicates new potential roles for Lp(a) in fibrinolysis and autoimmunity.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1482-1489
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Tsimikas, L. D. Tsironis, and A. D. Tselepis
New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2007;
27(10):
2094 - 2099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Licht, M. Haskins, P. Henthorn, S. E. Kleiman, D. M. Bodine, T. Whitwam, J. M. Puck, M. M. Gottesman, and J. R. Melniczek
Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow
PNAS,
February 20, 2002;
(2002)
52712199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Gaubatz, R. C. Hoogeveen, A. S. Hoffman, K. G. Ghazzaly, H. J. Pownall, J. Guevara Jr., M. L. Koschinsky, and J. D. Morrisett
Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins
J. Lipid Res.,
December 1, 2001;
42(12):
2058 - 2068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kobayashi, E. Matsuura, Q. Liu, J.-i. Furukawa, K. Kaihara, J. Inagaki, T. Atsumi, N. Sakairi, T. Yasuda, D. R. Voelker, et al.
A specific ligand for {beta}2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages
J. Lipid Res.,
May 1, 2001;
42(5):
697 - 709.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P A Gordon, J George, M A Khamashta, D Harats, G Hughes, and Y Shoenfeld
Atherosclerosis and autoimmunity
Lupus,
April 1, 2001;
10(4):
249 - 252.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Ma, R. Simantov, J.-C. Zhang, R. Silverstein, K. A. Hajjar, and K. R. McCrae
High Affinity Binding of beta 2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II
J. Biol. Chem.,
May 12, 2000;
275(20):
15541 - 15548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Lippi and G. Guidi
Lipoprotein(a): from ancestral benefit to modern pathogen?
QJM,
February 1, 2000;
93(2):
75 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J George, B Gilburd, P Langevitz, Y Levy, R Nezlin, D Harats, and Y Shoenfeld
{beta}2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels
Lupus,
February 1, 1999;
8(2):
116 - 120.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. Ohkura, Y. Hagihara, T. Yoshimura, Y. Goto, and H. Kato
Plasmin Can Reduce the Function of Human beta 2 Glycoprotein I by Cleaving Domain V Into a Nicked Form
Blood,
June 1, 1998;
91(11):
4173 - 4179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Klose, F. Fresser, S. Kochl, W. Parson, A. Kapetanopoulos, J. Fruchart-Najib, G. Baier, and G. Utermann
Mapping of a Minimal Apolipoprotein(a) Interaction Motif Conserved in Fibrin(ogen) beta - and gamma -Chains
J. Biol. Chem.,
December 1, 2000;
275(49):
38206 - 38212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sheng, S. W. Reddel, H. Herzog, Y. X. Wang, T. Brighton, M. P. France, S. A. Robertson, and S. A. Krilis
Impaired Thrombin Generation in beta 2-Glycoprotein I Null Mice
J. Biol. Chem.,
April 20, 2001;
276(17):
13817 - 13821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
